The Results Are Clear - A Scientifically
Proven Path to Targeting the Appearance of Hyperpigmentation and
Improving Skin Tone and Texture
IRVINE,
Calif., Jan. 17, 2023 /PRNewswire/ -- Today,
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the
launch of the long-awaited SkinMedica® Even &
Correct Collection. Clinically proven and formulated to deliver
targeted results, these three products work separately and together
to even skin tone and reduce the appearance of hyperpigmentation
and dark spots on the face: Advanced Brightening Treatment, Dark
Spot Cream, and Brightening Treatment Pads.
"Hyperpigmentation is the second-highest professional-grade
skincare concern seen in-office1 with demand for
effective treatment continuing to rise," said Carrie Strom, President, Global Allergan
Aesthetics and Senior Vice President, AbbVie. "With a formulation
backed by science, our R&D team has developed an innovative
collection to meet patients where they are in their
hyperpigmentation journey. SkinMedica® continues
to be a category leader innovating for all patient skin types."
"Hyperpigmentation is a complex, emotional condition that is
often misunderstood and can be difficult to treat as diverse skin
types and tones present with hyperpigmentation and respond to
treatment in different ways," said Dr. Corey L. Hartman, Board-certified dermatologist
and Founder of Skin Wellness Dermatology in Birmingham, AL. "My approach to
hyperpigmentation treatment for my patients are nuanced and
multimodal to treat existing discoloration and prevent future spots
by targeting the root cause. The collection is a customizable and
comprehensive approach that can be used together or individually to
help target a broad spectrum of unwanted hyperpigmentation
conditions, including melasma and post-inflammatory
hyperpigmentation (PIH) and effectively targets six critical
pathways associated with melanogenesis."
The SkinMedica® Even & Correct products
are hydroquinone-free, well tolerated, and effective on all skin
types and for multiple ethnicities. Results can be amplified
in-offices by receiving a DiamondGlow® treatment with Even &
Correct Advanced Brightening Pro-Infusion Serum.
"Patent-pending and exclusive to SkinMedica®, the LTN
Complex™ used in the Even & Correct collection
features Ultra-Concentrated Lotus Sprout Extract enriched in
phytochemicals through a specialized extraction process to harness
the most powerful properties that address skin discoloration,
Tranexamic Acid to reduce the appearance of dark spots and
Niacinamide to reduce the appearance of skin discoloration and fine
lines," said Dr. Prithwiraj Maitra, Executive Director, Global
Skincare R&D, Allergan Aesthetics. "In clinical studies,
individuals saw visibly brighter, more even skin tone in as little
as one week.2"
- SkinMedica® Even & Correct Advanced
Brightening Treatment: A powerful daily serum to help target
and prevent visible discoloration.
-
- 83% of patients agreed that "the serum improved the evenness of
my skin tone," at week 8 (n=108)
- 80% agreed "it makes my skin look less dull," at week 8
(n=108)
- 84% agreed "it improved the overall appearance of my skin," at
week 12 (n=110)
- SkinMedica® Even & Correct Dark Spot
Cream: A heavy-duty, targeted, fast-acting spot treatment
booster that minimizes the look of dark spots.
-
- 75% of patients agreed that "it improved the appearance of
uneven skin tone and discolorations," at week 8 (n=41)
- 74% agreed "it visibly reduced the size of dark spots," at week
8 (n=41)
- 78% agreed "it visibly reduced the size and intensity of my
uneven pigment," at week 8 (n=41)
- 78% agreed "it reduced the appearance of my sunspots," at week
12 (n=41)
- SkinMedica® Even & Correct Brightening
Treatment Pads: Alcohol-free brightening pads exfoliate and
help reduce the appearance of dullness and uneven tone and
texture.
SkinMedica® Even & Correct Advanced
Brightening Treatment ($178 MSRP),
SkinMedica® Even & Correct Dark Spot Cream
($88 MSRP), and
SkinMedica® Even & Correct Brightening
Treatment Pads ($60 MSRP) are
available for purchase at SkinMedica.com, and through a network of
licensed physicians and medically supervised spas. To experience
the SkinMedica® Even & Correct Advanced Brightening
Pro-Infusion Serum for DiamondGlow®, you can find a
provider near you by clicking here. For more information follow
@SkinMedica on Instagram or click here.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skincare,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information,
visit www.AllerganAesthetics.com.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
SkinMedica® IMPORTANT INFORMATION
CAUTION:
Do not use Even & Correct Dark Spot Cream if you are pregnant,
lactating, or planning to become pregnant.
Sunburn alert: Even & Correct Brightening Treatment Pads and
Even & Correct Dark Spot Cream contain an alpha-hydroxy acid
(AHA) that may increase your skin's sensitivity to sunburn. Use a
sunscreen and limit sun exposure while using these products and for
a week following discontinuation.
Use a sunscreen with an SPF of 30 or higher during any sun
exposure when using Even & Correct Advanced Brightening
Treatment.
Most SkinMedica® products are intended to meet the FDA's
definition of a cosmetic product, an article applied to the human
body to cleanse, beautify, promote attractiveness, and alter
appearances. These SkinMedica® products are not intended to be drug
products that diagnose, treat, cure, or prevent any disease or
condition. These products have not been approved by the FDA and the
statements have not been evaluated by the FDA.
DiamondGlow® Uses
The
DiamondGlow® device is a general dermabrasion device
that gently removes the top layer of skin and delivers topical
cosmetic serums onto the skin.
DiamondGlow® Important Safety
Information
The DiamondGlow® treatment is not for
everyone. You should not have a DiamondGlow® treatment
if you have compromised skin quality. Tell your provider if you are
pregnant or lactating, or if you have any medical conditions,
including allergies, and if you are using topical medications on
the area to be treated.
Typical side effects include a scratchy, stinging sensation
during the treatment and temporary tightness, redness or slight
swelling after the treatment. Rare serious side effects may also
occur and include severe skin irritation and allergic
reactions.
SkinMedica® Pro-Infusion Serums
Disclaimer
SkinMedica® Pro-Infusion Serums
are intended to meet the FDA's definition of a cosmetic product, an
article applied to the human body to cleanse, beautify, promote
attractiveness, and alter appearances. These products are not
intended to be drugs that diagnose, treat, cure, or prevent any
disease or condition. These products have not been approved by the
FDA and the statements have not been evaluated by the FDA.
Please talk to your provider for additional information.
For more information, please talk to your provider or
visit SkinMedica.com and DiamondGlow.com. To
report an adverse reaction, please call Allergan at
1-800-433-8871.
References:
- 2021 Kline Professional Skin Care Executive Study.
- Data on file at SkinMedica®.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/skinmedica-launches-even--correct-301721744.html
SOURCE AbbVie